← FDA Drug Approvals (Drugs@FDA)

REBLOZYL

BLA · Biologics License Application · Sponsor: CELGENE CORP · Approved 2019-11-08

Drug application

FDA Application #

BLA761136

Application type

Biologics License Application

Brand name

REBLOZYL

Generic name

LUSPATERCEPT

Active ingredients

LUSPATERCEPT-AAMT

Dosage form

POWDER

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

CELGENE CORP

Manufacturer

Celgene Corporation

First approval

2019-11-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown